These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5338893)

  • 21. The specificity of inhibition of tumor cell viability by DNA.
    Glick JL
    Cancer Res; 1967 Dec; 27(12):2338-41. PubMed ID: 4866763
    [No Abstract]   [Full Text] [Related]  

  • 22. Research on compounds with antiblastic activity. XXXV. Acylderivatives of some N-(omega-phthalimidoalkyl)arylamines: synthesis and antineoplastic activities.
    Artico M; De Martino G; Giuliano R
    Farmaco Sci; 1969 Feb; 24(2):191-8. PubMed ID: 5768829
    [No Abstract]   [Full Text] [Related]  

  • 23. Antitumor properties of 1,3-oxazine derivatives. I. Derivatives of 5-nitrotetrahydro-1,3-oxazines.
    Mordarski M; Chylińska B; Urbański T
    Arch Immunol Ther Exp (Warsz); 1970; 18(6):679-99. PubMed ID: 5493086
    [No Abstract]   [Full Text] [Related]  

  • 24. [Influencing the growth of malignant tumors with animal duodenal extracts in animal experiments].
    Hernuss P; Michalica W
    Osterr Z Erforsch Bekampf Krebskr; 1972; 27(5):307-11. PubMed ID: 4678900
    [No Abstract]   [Full Text] [Related]  

  • 25. [The mitosis rate in Jensen sarcoma, in a DANA lung carcinoma and in Ehrlich ascites tumor in iron deficiency and iron overloading].
    Kranz D; Schmidt UJ; Kalbe I; Brüschke G; Pasternak G
    Acta Biol Med Ger; 1969; 22(3):653-6. PubMed ID: 4903492
    [No Abstract]   [Full Text] [Related]  

  • 26. [The sensitivity of animal transplantable tumours to rubomycin].
    Maevskiĭ MM; Romanenko EA; Bondareva AS; Urazova AP; Avdeeva IA; Mazaeva VG; Timofeevskaia EA; Sedakova LA; Mol'kov IuN; Talyzina VA; Silant'ev VV
    Antibiotiki; 1967 Apr; 12(4):315-9. PubMed ID: 5584550
    [No Abstract]   [Full Text] [Related]  

  • 27. Interaction between the carcinostatic effects of x-rays and ibenzmethyzin on Ehrlich ascites carcinoma in mice.
    Rao KR
    Strahlentherapie; 1967 Dec; 134(4):574-84. PubMed ID: 5585415
    [No Abstract]   [Full Text] [Related]  

  • 28. [The antitumor properties of 3,5-diglycoside-cyanidine].
    Kabiev OK; Vermenichev SM
    Vopr Onkol; 1970; 16(8):60-2. PubMed ID: 5537238
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antitumor activity of doxorubicin in the treatment of hemocytoblastosis La and various ascites tumors in mice].
    Ul'ianova LA; Tarasova VE; Bazhanov VS; Iudina OI; Gol'dberg LE
    Antibiotiki; 1984 Nov; 29(11):861-6. PubMed ID: 6524889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental research in the influence of the endocrine status on the antiblastic activity of cytostatics.
    Zimel H
    Neoplasma; 1967; 14(4):345-52. PubMed ID: 6063010
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies with Proresid (SP-I) in various innoculation tumors].
    Osswald H; Schmähl D
    Med Klin; 1966 Apr; 61(17):681-4. PubMed ID: 5995181
    [No Abstract]   [Full Text] [Related]  

  • 32. Research on compounds with antiblastic acitvity. XXXIV. Derivatives of 3-p-aminophenyl-2-oxazolidinone: synthesis and antineoplastic activities.
    Artico M; De Martino G; Giuliano R
    Farmaco Sci; 1969 Feb; 24(2):179-90. PubMed ID: 5786383
    [No Abstract]   [Full Text] [Related]  

  • 33. [Results of the studies of ethyleneiminotriazines].
    Ivin BA; Kraĭz BO; Korsakov MV; Stukov AN; Sheĭman VP; Filov VA
    Vopr Onkol; 1990; 36(1):6-12. PubMed ID: 2407028
    [No Abstract]   [Full Text] [Related]  

  • 34. [Influence of bacterial RNA on protein synthesis and transplantability of Ehrlich ascitic carcinoma].
    Zerov IuP; Roschin VV; Ashmarin IP
    Tsitologiia; 1974 Mar; 16(3):352-7. PubMed ID: 4618682
    [No Abstract]   [Full Text] [Related]  

  • 35. [On sensitivity to sarcolysine of Ehrlich's ascites tumors in mice "vaccinated" with treated tumor cells from animals previously treated with sarcolysine alone or with other antineoplastic drugs (thioguanine, actinomycin D)].
    Bonmassar E; Melan F; Testorelli C
    Arch Ital Patol Clin Tumori; 1968; 11(1):229-44. PubMed ID: 5745130
    [No Abstract]   [Full Text] [Related]  

  • 36. Research on compounds with antiblastic activity. XXX. p-(N,N-bis-(beta-chloroethyl)amino)benzylidene derivatives of some cyclopentanones.
    Giuliano R; Ermili A; Artico M; Grundmann E; Bierling R; Steinhoff D
    Farmaco Sci; 1967 Apr; 22(4):258-71. PubMed ID: 5608225
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of glycyrrhizin on the evolution and respiration of Ehrlich ascites tumour cells.
    Rossi T; Galatulas I; Bossa R; Tampieri A; Tartoni P; Baggio G; Ruberto AI; Castelli M
    In Vivo; 1995; 9(3):183-6. PubMed ID: 8562878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Research on the antimitotic effect of treatment with combined pancreatic desoxyribonuclease and p-(N'-methylhydrazino-methyl)-N-iso-propyl-benzamide hydrochloride on the cells of Ehrlich's ascites tumor].
    Magliulo E; Petrocini S; Fossati GC; Gorini S
    Arch Sci Med (Torino); 1968 May; 125(5):179-84. PubMed ID: 5696482
    [No Abstract]   [Full Text] [Related]  

  • 39. [The use of cystophos in experimental chemotherapy of tumors].
    Aliev RG
    Vopr Onkol; 1966; 12(8):86-90. PubMed ID: 6002133
    [No Abstract]   [Full Text] [Related]  

  • 40. [New principle in the chemotherapy of tumors by modifying and transforming their cells into anaerobic-like cells].
    Petrovskii BV; Kogan AKh; Efuni SN; Chernov VA; Sinianskaia GP
    Patol Fiziol Eksp Ter; 1982; (2):45-51. PubMed ID: 6283461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.